The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Trimel Pharmaceuticals Corp

TSX: TRL
Delayed quote

$0.69

Today's change0.00 0.00%
Updated December 19 3:58 PM EST. Delayed by at least 15 minutes.
 

Trimel Pharmaceuticals Corp

TSX: TRL
Delayed quote

$0.69

Today's change0.00 0.00%
Updated December 19 3:58 PM EST. Delayed by at least 15 minutes.

Trimel Pharmaceuticals Corp closed at $0.69.

Shares have lost 1.43% over the last five days, but have gained 72.50% over the last year to date. This security has outperformed the S&P TSX by 64.47% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.17
Updated December 19 3:58 PM EST. Delayed by at least 15 minutes.
S&P TSX0.85%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue2000
Total other revenue--------
Total revenue2000
Gross profit0------
Total cost of revenue2------
Total operating expense76411
Selling / general / administrative1112
Research & development1429
Depreciation / amortization0110
Interest expense (income), net operating--------
Unusual expense (income)20----
Other operating expenses, total--------
Operating income-5-6-4-11
Interest income (expense), net non-operating-1000
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-7-3-10
Income after tax-5-7-3-10
Income tax, total0000
Net income-5-7-3-10
Total adjustments to net income--------
Net income before extra. items-5-7-3-10
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-5-7-3-10
Inc. avail. to common incl. extra. items-5-7-3-10
Diluted net income-5-7-3-10
Dilution adjustment----00
Diluted weighted average shares186163155148
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.05-0.02-0.07
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.01-0.05-0.02-0.07